Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG known ✓ | P37231 | 2/20 | 0.56 |
| ▸ | NR1I2 | O75469 | 4/20 | 0.70 |
| ▸ | PGR | P06401 | 3/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 9/20 | 0.64 |
| ▸ | MAPT | P10636 | 6/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.64 |
| ▸ | APEX1 | P27695 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | POLB | P06746 | 3/20 | 0.64 |
| ▸ | RECQL | P46063 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | DAO | P14920 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10640931 | 0.97 | NR1I2 (0.69) | NR1I2PGRTDP1MAPTHSD17B10 | |
| SCHEMBL10633665 | 0.94 | NR1I2 (0.80) | NR1I2PGRTDP1MAPTHSD17B10 | |
| SCHEMBL10999424 | 0.94 | NR1I2 (0.61) | NR1I2PGRTDP1MAPTHSD17B10 | |
| SCHEMBL11000502 | 0.94 | NR1I2 (0.61) | NR1I2PGRTDP1MAPTHSD17B10 | |
| SCHEMBL10996849 | 0.94 | NR1I2 (0.61) | NR1I2PGRTDP1MAPTHSD17B10 | |
| SCHEMBL10640295 | 0.93 | NR1I2 (0.73) | NR1I2PGRTDP1MAPTHSD17B10 | |
| Cefmenoxime SCHEMBL10776181 | 0.89 | NR1I2 (0.88) | NR1I2PGRTDP1MAPTHSD17B10 | |
| Cefmenoxime SCHEMBL10776170 | 0.89 | NR1I2 (0.88) | NR1I2PGRTDP1MAPTHSD17B10 | |
| Cefmenoxime SCHEMBL9651055 | 0.89 | NR1I2 (0.88) | NR1I2PGRTDP1MAPTHSD17B10 | |
| Cefmenoxime SCHEMBL15660878 | 0.89 | NR1I2 (0.88) | NR1I2PGRTDP1MAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4742174-A | MICROBTOCIDES | TANABE SEIYAKU CO., LTD. (JP) | 1988-05-03 | — | — | US | disclosed |
| US-4727071-A | MICROBIOCIDES | TANABE SEIYAKU CO., LTD. (JP) | 1988-02-23 | — | — | US | disclosed |
| US-4598154-A | Thiazole intermediates for cephalosporin compounds | TANABE SEIYAKU CO., LTD. (JP) | 1986-07-01 | — | — | US | disclosed |
| US-4598075-A | ANTIMICROBIAL | TANABE SEIYAKU CO., LTD. (JP) | 1986-07-01 | — | — | US | disclosed |